Exchange: NASDAQ·Updated 07:34 PM EDT
SRTA logo

SRTAStrata Critical Medical Inc

$5.04
$0.05
(0.98%)
Today
Closed $5.04
$0.00
(0.00%)
After Hours
Mkt Cap$436.09M
Vol1.08M
News
all
press releases
Strata Critical Medical, Inc. (SRTA) Surges 8.5%: Is This an Indication of Further Gains?
Strata Critical Medical, Inc. (SRTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
More News
Strata Critical Medical Q1 2026 Earnings Call: Complete Transcript
read more...
Benzinga
Cathie Wood's Ark keeps selling one stock once again
Cathie Wood, head of Ark Investment Management, is known for making bold, conviction-driven bets, but she's just as quick to trim positions when the strategy shifts. That pattern is playing out again...
TheStreet.com
Strata Critical Medical (NASDAQ:SRTA) Upgraded to Hold at Zacks Research
Zacks Research raised Strata Critical Medical to a "hold" rating in a research report on Thursday...
MarketBeat
Strata Critical Medical (NASDAQ:SRTA) Now Covered by Analysts at Craig Hallum
Craig Hallum assumed coverage on Strata Critical Medical in a research report on Wednesday. They issued a "buy" rating and a $8.00 price objective on the stock...
MarketBeat
Strata Critical Medical (SRTA) Earnings Call
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Earnings Outlook For Strata Critical Medical
read more...
Benzinga
AMN Healthcare Services (AMN) Beats Q3 Earnings and Revenue Estimates
AMN Healthcare (AMN) delivered earnings and revenue surprises of +105.26% and +3.15%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Biodesix, Inc. (BDSX) Reports Q3 Loss, Tops Revenue Estimates
Biodesix (BDSX) delivered earnings and revenue surprises of +27.50% and +2.68%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Strength Seen in Teladoc (TDOC): Can Its 6.3% Jump Turn into More Strength?
Teladoc (TDOC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks
<
1
2
...
>

Advertisement|Remove ads.